Stryker's income up 20% on 6% sales increase:
This article was originally published in Clinica
Stryker's first-quarter sales increased 6% to $254 million, while net income rose 20% to $36 million. Kalamazoo, Michigan-based Stryker's domestic sales were up 14% to $171 million and were boosted by strong shipments of endoscopic equipment, powered surgical instruments and orthopaedics implants. International sales, hit by lower business to the Asian market and the exchange rate effects, fell 8% to $82 million.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.